Search for: "HOSPIRA, INC."
Results 241 - 260
of 287
Sorted by Relevance
|
Sort by Date
27 Oct 2010, 7:27 am
Food and Drug Administration; that company is Hospira, Inc. [read post]
25 Mar 2011, 1:01 pm
The shortage started last year, after Hospira Inc., the sole U.S. manufacturer of the drug and the only sodium-thiopental maker approved by the Food and Drug Administration, stopped making it. [read post]
17 Mar 2020, 1:32 pm
Lidocaine HCl Topical Solution 4%, 50ml, has been recalled by Teligent Pharma, Inc. due to super potency. [read post]
10 Sep 2018, 10:17 am
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
21 Feb 2018, 7:45 pm
Berman, Case IPR2016-01571 (PTAB Dec. 14, 2016) (Paper 10) Hospira, Inc. v. [read post]
23 Mar 2022, 8:23 am
Hospira, Inc., 52 F. [read post]
15 Jun 2011, 11:03 pm
Hospira, Inc., 637 F.3d 1341, 1343-44 (Fed. [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
15 Dec 2014, 7:25 am
.* Hurray for judicial sense on product by process claims- Birss triumphs in Hospira v GenentechThis note from Darren is about Hospira v Genentech [on which see the IPKat note here], a pharma-patent case that Mr Justice Birss has decided in light of product-by-process claims. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
24 Sep 2010, 9:31 am
"Hospira Inc. of Lake Forest, Ill., said in letters sent earlier this year to prison officials in all 50 states that it "provides the products because they improve or save lives and markets them solely for the purpose indicated on the product labeling. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
2 Jul 2011, 11:02 am
Except Hospira stopped making thiopental. [read post]
28 Sep 2010, 8:07 pm
The manufacturer, Hospira Inc., has said that new supplies will not be available until at least January 2011. [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
19 May 2011, 9:53 am
The corrections department changed its protocol to use pentobarbital instead of sodium thiopental in its lethal injection cocktail after Hospira Inc., the only U.S. supplier of sodium thiopental, announced earlier this year it would no longer manufacture the drug. [read post]
22 Apr 2011, 9:26 am
The drug has been in short supply since last year and the only U.S. manufacturer, Hospira Inc., is ending production because of death-penalty opposition overseas. [read post]
29 May 2012, 8:08 am
The drug hasn’t been sold in the U.S. since 2009, when the sole U.S. manufacturer, Hospira Inc. [read post]
2 Dec 2011, 2:00 pm
Hospira, Inc., 2011 WL 3439145, at *6 (M.D.N.C. [read post]
